CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Clotrimazole

克霉唑 杂质对照品Clotrimazole Impurities

EP32 个杂质条目32 impurity entries

本页汇总 克霉唑 的 32 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Clotrimazole with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 克霉唑(Clotrimazole)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and validation of HPLC method for determination of clotrimazole and its two degradation products in spray formulation
    Talanta · 2007 · Hájková R et al.  ·  PMID 19073060  ·  DOI
  2. 分析方法Analytical MethodsChromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations
    Farmaco (Societa chimica italiana : 1989) · 2002 · Abdel-Moety EM et al.  ·  PMID 12484542  ·  DOI
  3. 分析方法Analytical MethodsDevelopment of a Method for the Quantification of Clotrimazole and Itraconazole and Study of Their Stability in a New Microemulsion for the Treatment of Sporotrichosis
    Molecules (Basel, Switzerland) · 2019 · Garcia Ferreira P et al.  ·  PMID 31242573  ·  DOI
  4. 分析方法Analytical MethodsA comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2024 · Wellington H et al.  ·  PMID 37992910  ·  DOI
  5. 分析方法Analytical MethodsStability of non-aqueous topical tetracaine and clotrimazole solutions in polypropylene droptainer bottles
    International journal of pharmaceutical compounding · 2013 · McPherson TB et al.  ·  PMID 24579301

克霉唑 —— 原料药与杂质对照品Clotrimazole — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Clotrimazole structure
EP原料药 APIAPI
克霉唑Clotrimazole
Clotrimazole
CAS No.23593-75-1
Chemical FormulaC22H17ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 1(Clotrimazole EP Impurity A) structure
EPA
克霉唑杂质1(克霉唑EP杂质A)Clotrimazole Impurity 1(Clotrimazole EP Impurity A)
Clotrimazole Impurity 1(Clotrimazole EP Impurity A)
CAS No.66774-02-5
Chemical FormulaC19H15ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 2(Clotrimazole EP Impurity B) structure
EPB
克霉唑杂质2(克霉唑EP杂质B)Clotrimazole Impurity 2(Clotrimazole EP Impurity B)
Clotrimazole Impurity 2(Clotrimazole EP Impurity B)
CAS No.23593-71-7
Chemical FormulaC22H17ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 3(Clotrimazole EP Impurity C) structure
EPC
克霉唑杂质3(克霉唑EP杂质C)Clotrimazole Impurity 3(Clotrimazole EP Impurity C)
Clotrimazole Impurity 3(Clotrimazole EP Impurity C)
CAS No.42074-68-0
Chemical FormulaC19H14Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 5(Clotrimazole EP Impurity E) structure
EPE
克霉唑杂质5(克霉唑EP杂质E)Clotrimazole Impurity 5(Clotrimazole EP Impurity E)
Clotrimazole Impurity 5(Clotrimazole EP Impurity E)
CAS No.5162-03-8
Chemical FormulaC13H9ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 6(Clotrimazole EP Impurity F) structure
EPF
克霉唑杂质6(克霉唑EP杂质F)Clotrimazole Impurity 6(Clotrimazole EP Impurity F)
Clotrimazole Impurity 6(Clotrimazole EP Impurity F)
CAS No.15469-97-3
Chemical FormulaC22H18N2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 7 structure
7
克霉唑杂质7Clotrimazole Impurity 7
Clotrimazole Impurity 7
CAS No.2136-89-2
Chemical FormulaC7H4Cl4
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 8 structure
8
克霉唑杂质8Clotrimazole Impurity 8
Clotrimazole Impurity 8
CAS No.289905-88-0
Chemical FormulaC22H17ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 9 structure
9
克霉唑杂质9Clotrimazole Impurity 9
Clotrimazole Impurity 9
CAS No.3509-85-1
Chemical FormulaC13H9Cl3
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 10 structure
10
克霉唑杂质10Clotrimazole Impurity 10
Clotrimazole Impurity 10
CAS No.56153-60-7
Chemical FormulaC19H15Cl
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 11 structure
11
克霉唑杂质11Clotrimazole Impurity 11
Clotrimazole Impurity 11
CAS No.968-39-8
Chemical FormulaC21H20O
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 12 structure
12
克霉唑杂质12Clotrimazole Impurity 12
Clotrimazole Impurity 12
CAS No.6922-89-0
Chemical FormulaC19H15ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 13 structure
13
克霉唑杂质13Clotrimazole Impurity 13
Clotrimazole Impurity 13
CAS No.5216-25-1
Chemical FormulaC7H4Cl4
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 16 structure
16
克霉唑杂质16Clotrimazole Impurity 16
Clotrimazole Impurity 16
CAS No.59154-29-9
Chemical FormulaC19H14Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 17 structure
17
克霉唑杂质17Clotrimazole Impurity 17
Clotrimazole Impurity 17
CAS No.29647-82-3
Chemical FormulaC19H15ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 18 structure
18
克霉唑杂质18Clotrimazole Impurity 18
Clotrimazole Impurity 18
CAS No.27023-37-6
Chemical FormulaC19H14Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 19 structure
19
克霉唑杂质19Clotrimazole Impurity 19
Clotrimazole Impurity 19
CAS No.29921-41-3
Chemical FormulaC13H11Cl
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 20 structure
20
克霉唑杂质20Clotrimazole Impurity 20
Clotrimazole Impurity 20
CAS No.17849-38-6
Chemical FormulaC7H7ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 21 structure
21
克霉唑杂质21Clotrimazole Impurity 21
Clotrimazole Impurity 21
CAS No.822-36-6
Chemical FormulaC4H6N2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 22 structure
22
克霉唑杂质22Clotrimazole Impurity 22
Clotrimazole Impurity 22
CAS No.23593-76-2
Chemical FormulaC22H17ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 23 structure
23
克霉唑杂质23Clotrimazole Impurity 23
Clotrimazole Impurity 23
CAS No.98751-53-2
Chemical FormulaC23H19ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 24 structure
24
克霉唑杂质24Clotrimazole Impurity 24
Clotrimazole Impurity 24
CAS No.289887-34-9
Chemical FormulaC23H19ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 25 structure
25
克霉唑杂质25Clotrimazole Impurity 25
Clotrimazole Impurity 25
CAS No.717109-43-8
Chemical FormulaC21H19ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 26 structure
26
克霉唑杂质26Clotrimazole Impurity 26
Clotrimazole Impurity 26
CAS No.717109-42-7
Chemical FormulaC20H17ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 27 structure
27
克霉唑杂质27Clotrimazole Impurity 27
Clotrimazole Impurity 27
CAS No.1080636-35-6
Chemical FormulaC10H9ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 29 structure
29
克霉唑杂质29Clotrimazole Impurity 29
Clotrimazole Impurity 29
CAS No.37595-08-7
Chemical FormulaC22H16Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 30 structure
30
克霉唑杂质30Clotrimazole Impurity 30
Clotrimazole Impurity 30
CAS No.35645-27-3
Chemical FormulaC22H16Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 31 structure
31
克霉唑杂质31Clotrimazole Impurity 31
Clotrimazole Impurity 31
CAS No.66774-01-4
Chemical FormulaC19H14Cl2O
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 32 structure
32
克霉唑杂质32Clotrimazole Impurity 32
Clotrimazole Impurity 32
CAS No.119123-41-0
Chemical FormulaC19H14Cl2O
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 33 structure
33
克霉唑杂质33Clotrimazole Impurity 33
Clotrimazole Impurity 33
CAS No.13524-04-4
Chemical FormulaC8H9ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 36 structure
36
克霉唑杂质36Clotrimazole Impurity 36
Clotrimazole Impurity 36
CAS No.14470-28-1
Chemical FormulaC20H17ClO
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 37 structure
37
克霉唑杂质37Clotrimazole Impurity 37
Clotrimazole Impurity 37
CAS No.23429-44-9
Chemical FormulaC20H17Cl
Purity>95%询价On request
10mg25mg50mg100mg
Clotrimazole Impurity 21-d3 structure
21-D3
克霉唑杂质21-d3Clotrimazole Impurity 21-d3
Clotrimazole Impurity 21-d3
CAS No.1219805-95-4
Chemical FormulaC4H3D3N2
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

克霉唑 —— 研究文献与合成路线Clotrimazole — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 克霉唑 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Clotrimazole. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-/Akt-mediated tyrosinase degradation
    Chung BY, Kim SY, Jung JM, et al. · Experimental dermatology · 2015 · 被引 12cited 12
  2. Development and validation of HPLC method for determination of clotrimazole and its two degradation products in spray formulation
    Hájková R, Sklenárová H, Matysová L, et al. · Talanta · 2007 · 被引 12cited 12
  3. Monitoring of Clotrimazole Degradation Pathway in Presence of its Co-formulated Drug
    Tawakkol SM, Fayez YM, Fahmy NM, et al. · Journal of chromatographic science · 2019 · 被引 2cited 2
  4. Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations
    Abdel-Moety EM, Khattab FI, Kelani KM, et al. · Farmaco (Societa chimica italiana : 1989) · 2002 · 被引 32cited 32
  5. High performance liquid chromatographic determination of clotrimazole in pharmaceutical formulations
    Hoogerheide JG, Strusiak SH, Taddei CR, et al. · Journal - Association of Official Analytical Chemists · 1981 · 被引 9cited 9
  6. Simultaneous ecofriendly HPLC determination of clotrimazole, miconazole, metronidazole, and lidocaine in pharmaceutical dosage forms
    Zhuravel A, Piponski M, Kopilevych V, et al. · BMC chemistry · 2026 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. A MEDICINAL CREAM MADE USING CLOTRIMAZOLE AND CHITOSAN AND A PROCESS TO MAKE THE SAME
    SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, GHOSH KAUSIK · 公开号 EP2419084EP2419084 · 2012
  2. A MEDICINAL CREAM MADE USING CLOTRIMAZOLE AND CHITOSAN AND A PROCESS TO MAKE THE SAME
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, GHOSH KAUSIK · 公开号 WO2010119365WO2010119365 · 2010
  3. A MEDICINAL CREAM MADE USING CLOTRIMAZOLE, FLUTICASONE PROPIONATE, AND CHITOSAN, AND A PROCESS TO MAKE THE SAME
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, SENTHILKUMAR KUPPUSAMY · 公开号 WO2010119386WO2010119386 · 2010
  4. A MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING, BIOPOLYMER, BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE AND A PROCESS TO MAKE IT
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, HARIDAS SANKAR · 公开号 WO2012017381WO2012017381 · 2012
  5. A MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING A BIOPOLYMER, CLOTRIMAZOLE AND CLOBETASONE, AND A PROCESS TO MAKE IT
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, SENTHILKUMAR KUPPUSAMY, et al. · 公开号 WO2011101825WO2011101825 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

克霉唑 杂质谱研究要点Clotrimazole — impurity profiling notes

下面这些是拿到 克霉唑 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Clotrimazole, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances